Cronos (CRON) Cost of Revenue (2018 - 2026)
Cronos' (CRON) quarterly Cost of Revenue came in at $26.1 million in Q1 2026, up 735.85% year-on-year from $3.1 million in Q1 2025, and down 8.06% quarter-over-quarter from $28.3 million in Q4 2025.
Cronos (CRON) Cost of Revenue (2018 - 2026) Analysis & Trends
Cronos' Cost of Revenue history runs 9 years deep, the most recent figure standing at $26.1 million for Q1 2026.
- On a quarterly basis, Cost of Revenue rose 735.85% year-over-year to $26.1 million in Q1 2026; TTM through Mar 2026 was $81.2 million, a 119.42% increase from a year earlier, with the FY2025 full-year figure at $83.8 million, up 636.24% from the prior year.
- Cost of Revenue retreated to $26.1 million in Q1 2026 per CRON's latest filing, from $28.3 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $32.4 million in Q2 2024 and bottomed at -$43.4 million in Q4 2022.
- The 5-year median for Cost of Revenue is $17.7 million (2022), against an average of $11.9 million.
- Across the five-year window, Cost of Revenue slumped 1047.09% in 2022 and soared 735.85% in 2026, its largest moves.
- Year by year, Cost of Revenue stood at -$43.4 million in 2022, then surged by 113.45% to $5.8 million in 2023, then jumped by 49.27% to $8.7 million in 2024, then jumped by 225.06% to $28.3 million in 2025, then decreased by 8.06% to $26.1 million in 2026.
- Per Business Quant, the three latest CRON Cost of Revenue figures stand at $26.1 million (Q1 2026), $28.3 million (Q4 2025), and $30.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.01 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 641.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 2.59 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 133.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 2.36 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 13.80 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 586.00 Mn |
| 10 | Cronos | 1.08 Bn | 261.26 Mn | 19.15 Mn | 26.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.06 Mn |
| Mar 31, 2026 | 26.06 Mn |
| Dec 31, 2025 | 28.34 Mn |
| Dec 31, 2025 | 28.34 Mn |
| Sep 30, 2025 | 30.50 Mn |
| Sep 30, 2025 | 30.50 Mn |
| Jun 30, 2025 | -3.71 Mn |
| Jun 30, 2025 | -3.71 Mn |
| Mar 31, 2025 | -4.10 Mn |
| Mar 31, 2025 | -4.10 Mn |
| Sep 30, 2024 | 8.72 Mn |
| Sep 30, 2024 | 8.72 Mn |
| Jun 30, 2024 | 32.38 Mn |
| Jun 30, 2024 | 32.38 Mn |
| Mar 31, 2024 | 20.81 Mn |
| Mar 31, 2024 | 20.81 Mn |
| Dec 31, 2023 | 5.84 Mn |
| Dec 31, 2023 | 5.84 Mn |
| Sep 30, 2023 | 4.23 Mn |
| Sep 30, 2023 | 4.23 Mn |